Research Article

The Positive and Negative Effects of Calcium Supplementation on Mortality in Septic ICU Patients Depend on Disease Severity: A Retrospective Study from the MIMIC-III

Table 1

The clinical characteristics of septic patients with different levels of iCa at the first ICU admission.

Clinical parametersTotal (n = 2,694)Hypocalcemia (<1.15 mmol/L; n = 1,889, 70.12%)Normal (1.15∼1.30 mmol/L; n = 716, 26.58%)Hypercalcemia (>1.30 mmol/L; n = 89, 3.30%) value

Age (years; median, Q1Q3)64.40 (52.05∼77.19)63.39 (50.82∼76.56)66.92 (56.45∼78.30)64.31 (53.87∼80.51)<0.0001
Sex (male; n, %)1579 (58.61)1099 (58.18)427 (59.64)53 (59.55)0.783
Ethnicity (n, %)
White1905 (70.71)1312 (69.45)534 (74.58)59 (66.29)0.024
Black197 (7.31)131 (6.93)56 (7.82)10 (11.24)0.253
Hispanic/Latino79 (2.93)67 (3.54)9 (1.26)3 (3.37)0.010
Others513 (19.04)379 (20.06)117 (16.34)17 (19.10)0.097
Severity
SOFA (mean ± SD)6.33 ± 3.666.47 ± 3.805.84 ± 3.197.23 ± 3.870.001
SIRS (mean ± SD)3.09 ± 0.873.13 ± 0.873.00 ± 0.863.00 ± 1.030.070
LODS (mean ± SD)5.66 ± 3.165.71 ± 3.255.41 ± 2.866.62 ± 3.470.020
qSOFA (mean ± SD)1.98 ± 0.671.96 ± 0.672.00 ± 0.682.05 ± 0.670.370
Septic shock (n, %)423 (15.70)339 (17.94)74 (10.34)10 (11.24)<0.0001
Vent (n, %)1998 (74.16)1388 (73.47)542 (75.70)68 (76.64)0.455
Lactate (median, Q1Q3)1.90 (1.20∼3.10)1.90 (1.30∼3.22)1.70 (1.10∼2.60)3.10 (1.80∼5.40)<0.0001
28-day mortality (n, %)478 (17.74)354 (18.74)104 (14.53)20 (22.47)0.008
Hospital mortality (n, %)500 (18.53)371 (19.64)109 (15.22)20 (22.47)0.006
ICU LOS (days; median, Q1Q3)3.37 (1.86∼7.27)3.57 (1.90∼7.79)3.10 (1.66∼6.23)2.84 (1.761∼5.68)0.002
Hospital LOS (days; median, Q1Q3)8.98 (5.44∼15.01)8.97 (5.36∼15.44)8.95 (5.71∼13.87)9.69 (5.16∼13.66)0.861

SOFA, sequential organ failure assessment; qSOFA, quick sequential organ failure assessment; SIRS, systemic inflammatory response syndrome, LODS, logistic organ dysfunction system; ICU LOS, intensive care unit length of stay; Hospital LOS, hospital length of stay.